Valuation: Ibnsina Pharma

Market Cap 11.09B 210M 188M 175M 159M 298M 19.94B 301M 2.09B 820M 10.37B 789M 771M 33.27B P/E 2026 *
9.73x
P/E 2027 * 7.45x
Enterprise Value 17.84B 338M 302M 281M 255M 480M 32.08B 484M 3.37B 1.32B 16.68B 1.27B 1.24B 53.54B EV / Sales 2026 *
0.2x
EV / Sales 2027 * 0.17x
Free-Float
58.26%
Yield 2026 *
2.41%
Yield 2027 * 3.73%
1 day-2.31%
1 week-5.98%
Current month-4.35%
1 month-13.79%
3 months-4.10%
6 months+5.36%
Current year-6.14%
1 week 10.03
Extreme 10.03
11.72
1 month 10.03
Extreme 10.03
12.74
Current year 9.63
Extreme 9.63
16.93
1 year 9.63
Extreme 9.63
16.93
3 years 1.88
Extreme 1.883
16.93
5 years 1.1
Extreme 1.101
16.93
10 years 1.1
Extreme 1.101
16.93
Manager TitleAgeSince
Chief Executive Officer - 2000-12-17
Chief Executive Officer - 2000-12-17
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member - 2000-12-17
Director/Board Member - 2000-12-17
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-2.31%-5.98%-7.56%+487.61% 210M
+12.70%-2.77%+13.10%-23.99% 7.23B
+0.02%+1.29%-15.68%-2.53% 6.13B
-0.19%+1.25%-14.84%+1.20% 6.06B
+1.04%+8.32%+2.98%-9.63% 4.57B
-1.35%+4.07%+13.96%-21.96% 3.22B
-1.10%-2.34%-26.30%-12.51% 3.13B
-0.06%-1.92%-26.01%-36.74% 3.1B
+9.46%+12.52%-35.22%-7.86% 3.33B
+0.87%-1.97%-29.76%+27.34% 2.84B
Average +1.89%+2.56%-12.53%+40.09% 3.98B
Weighted average by Cap. +3.03%+3.97%-10.02%-7.42%

Financials

2026 *2027 *
Net sales 90.78B 1.72B 1.54B 1.43B 1.3B 2.44B 163B 2.46B 17.15B 6.71B 84.89B 6.46B 6.32B 272B 103B 1.95B 1.74B 1.62B 1.47B 2.77B 185B 2.79B 19.42B 7.6B 96.11B 7.31B 7.15B 308B
Net income 1.18B 22.41M 20.02M 18.66M 16.92M 31.83M 2.13B 32.08M 224M 87.5M 1.11B 84.16M 82.31M 3.55B 1.58B 29.98M 26.78M 24.96M 22.63M 42.59M 2.85B 42.92M 299M 117M 1.48B 113M 110M 4.75B
Net Debt 6.75B 128M 114M 107M 96.58M 182M 12.14B 183M 1.28B 500M 6.32B 481M 470M 20.27B 6.81B 129M 115M 107M 97.43M 183M 12.25B 185M 1.29B 504M 6.37B 485M 474M 20.45B
Projected Income Statement - Annual - Ibnsina Pharma
Logo Ibnsina Pharma
Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.
Employees
5,500
Date Price Change Volume
26-10-13 EGP 11.00 -2.31% 6,201,904
26-10-12 EGP 11.26 -1.23% 2,552,686
26-10-11 EGP 11.40 -2.56% 3,280,885
26-10-07 EGP 11.70 0.00% 1,872,122
26-10-06 EGP 11.70 -1.52% 3,996,522
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Ibnsina Pharma
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
11.00EGP
Average target price
16.51EGP
Spread / Average Target
+50.07%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Ibnsina Pharma
  1. Stock Market
  2. Stocks
  3. ISPH Stock